Fayez Sarofim & Co’s Maxim Integrated Products MXIM Stock Holding History

Fayez Sarofim & Co’s Portfolio MXIM Stock Details MXIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,598	Closed	-$484K	–	321
2021 Q2	$484K	Hold	4,598	–	–	﹤0.01%	251
2021 Q1	$420K	Sell	4,598 -400	-8%	-$36.7K	﹤0.01%	224
2020 Q4	$443K	Buy	4,998 +562	+13%	+$44.3K	﹤0.01%	221
2020 Q3	$300K	Hold	4,436	–	–	﹤0.01%	233
2020 Q2	$269K	Hold	4,436	–	–	﹤0.01%	230
2020 Q1	$216K	Hold	4,436	–	–	﹤0.01%	225
2019 Q4	$273K	Buy	4,436 +295	+7%	+$17.2K	﹤0.01%	240
2019 Q3	$240K	Buy	4,141 +105	+3%	+$6.08K	﹤0.01%	234
2019 Q2	$241K	Hold	4,036	–	–	﹤0.01%	235
2019 Q1	$215K	Hold	4,036	–	–	﹤0.01%	238
2018 Q4	$205K	Hold	4,036	–	–	﹤0.01%	231
2018 Q3	$228K	Hold	4,036	–	–	﹤0.01%	228
2018 Q2	$237K	Sell	4,036 -158	-4%	-$9.2K	﹤0.01%	227
2018 Q1	$253K	Hold	4,194	–	–	﹤0.01%	225
2017 Q4	$219K	Buy	+4,194	New	+$218K	﹤0.01%	237

Other funds holding MXIM

CCM

Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Rowlandmiller & Partners Atlanta, Georgia $493M AUM 17.89% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Fayez Sarofim & Co's MXIM Position: Q3 2021 in Review

Fayez Sarofim & Co sold out of Maxim Integrated Products (MXIM) in Q3 2021, closing a stake of 4,598 shares — an estimated $484K sold.

Fayez Sarofim & Co first reported a position in MXIM in Q4 2017 and held it in 15 quarters. The position peaked at $484K in Q2 2021. 3 funds tracked by Wall St. Rank hold MXIM as of Q3 2021.

Fayez Sarofim & Co reported no remaining Maxim Integrated Products position as of Q3 2021 after selling out during the quarter.
Fayez Sarofim & Co sold 4,598 Maxim Integrated Products shares in Q3 2021, an estimated $484K.
Fayez Sarofim & Co first reported a position in Maxim Integrated Products in Q4 2017 and held it in 15 quarters.
Fayez Sarofim & Co's Maxim Integrated Products position peaked at $484K in Q2 2021.
3 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q3 2021.

Based on Fayez Sarofim & Co's 13F filing for Q3 2021, filed 15 Nov 2021.